Showing results (161-170 of 320) with videos related to

Sort By:
Pageof 32
The Journal of Rheumatology|November 18, 2008
A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritisIvan Foeldvari, Ilona S Szer, Lawrence S Zemel, et al.
The Journal of Rheumatology|February 2, 2022
COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to ControlsLihi Eder, Ruth Croxford, Aaron M Drucker, et al.
Arthritis Care & Research|September 6, 2021
Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 TestingLihi Eder, Ruth Croxford, Aaron M Drucker, et al.
Clinical and Experimental Rheumatology|August 6, 2016
Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoringClare E Pain, Tamás Constantin, Natasa Toplak, et al.
Arthritis Research & Therapy|October 30, 2020
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registryGiulia Armaroli, Ariane Klein, Gerd Ganser, et al.
The Journal of Rheumatology|January 17, 2012
Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon diseaseSindhu R Johnson, John T Granton, George A Tomlinson, et al.
Lancet (London, England)|July 9, 2023
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trialAthimalaipet V Ramanan, Pierre Quartier, Nami Okamoto, et al.
Arthritis Research & Therapy|November 6, 2019
Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic diseaseWaleed Hafiz, Rawad Nori, Ariana Bregasi, et al.
Rheumatology (Oxford, England)|June 27, 2021
Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individualsCarolina Muñoz-Grajales, Stephenie D Prokopec, Sindhu R Johnson, et al.
Arthritis Care & Research|November 14, 2024
Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open-Label, Phase 1 TrialHermine I Brunner, Anna Shmagel, Gerd Horneff, et al.
Pageof 32